Frélii, Inc. provides consumer affordable access to personalized health assessments and nutrition plans based on genetic data, physiology, environmental and lifestyle factors, and lab diagnostics all on one convenient web platform. The company is headquartered in Lehi, Utah. The company went IPO on 2005-01-18. The firm provides users personalized, deoxyribonucleic acid (DNA)-based diet and nutrition plans and identifies users’ health risks. Users can upload their raw genetic data by logging into their 23andMe profile and the Company’s site uploads that data for use by its artificial intelligence (AI)-based algorithm. Its products include KDIR, EZV-200, BLDB Tonic, Keotone-CoCoa and CTV. The firm provides tools, which includes personalized cookbook, meal planning, shopping lists, supplement packages and video workouts. The company provides Navii, which is computer learning-based algorithm generates insight about individual genetic health risks, and assists health providers to identify and treat various health concerns. Its wellness plans feature nutrition and fitness plans, supplement recommendations, downloadable menus, recipes, and shopping lists, and virtual personal training.
Follow-Up Questions
Frelii Inc (FRLI)의 PER은 얼마입니까?
Frelii Inc의 PER은 0입니다
Frelii Inc의 CEO는 누구입니까?
Mr. Ian Jenkins은 2017부터 회사에 합류한 Frelii Inc의 Chief Executive Officer입니다.
FRLI 주식의 가격 성능은 어떻습니까?
FRLI의 현재 가격은 $0.0001이며, 전 거래일에 decreased 0% 하였습니다.
Frelii Inc의 주요 사업 주제나 업종은 무엇입니까?
Frelii Inc은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
